國立虎尾科技大學 |

Diabetic retinopathy = current pharmacologic treatment and emerging strategies /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Diabetic retinopathy/ by Michael W. Stewart.
其他題名:	current pharmacologic treatment and emerging strategies /
作者:	Stewart, Michael W.
出版者:	Singapore :Springer Singapore : : 2017.,
面頁冊數:	xiii, 268 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Diabetic retinopathy. -
電子資源:	http://dx.doi.org/10.1007/978-981-10-3509-8
ISBN:	9789811035098

Diabetic retinopathy = current pharmacologic treatment and emerging strategies /
Stewart, Michael W.

Diabetic retinopathycurrent pharmacologic treatment and emerging strategies /[electronic resource] :by Michael W. Stewart. - Singapore :Springer Singapore :2017. - xiii, 268 p. :ill., digital ;24 cm.

1. Diabetes and Diabetic Retinopathy: Overview Of A World-Wide Epidemic -- 2. The Diabetic Retina: Anatomy and Pathophysiology -- 3. Treatment of Diabetic Retinopathy: A Historical Perspective -- 4. Targeting Vascular Endothelial Growth Factor -- 5. Corticosteroids: Targeting Multiple Cytokines and Chemokines -- 6. Current Treatment Recommendations -- 7. Vitreolysis: Targeting the Vitreoretinal Interface -- 8. Investigational Medications -- 9. Safety Considerations of Pharmacotherapy -- 10. Socioeconomic Cost of Diabetic Retinopathy and Therapy.

A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets. Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option. Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed.

ISBN: 9789811035098

Standard No.: 10.1007/978-981-10-3509-8doiSubjects--Topical Terms:

781324
Diabetic retinopathy.

LC Class. No.: RE661.D5

Dewey Class. No.: 617.735

Diabetic retinopathy = current pharmacologic treatment and emerging strategies /
LDR:02624nam a2200325 a 4500 001 884977
003 DE-He213
005 20170407113637.0
006 m d
007 cr nn 008maaau
008 180530s2017 si s 0 eng d
020 $a 9789811035098 $q (electronic bk.)
020 $a 9789811035081 $q (paper)
024 7 $a 10.1007/978-981-10-3509-8 $2 doi
035 $a 978-981-10-3509-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RE661.D5
072 7 $a MJGD $2 bicssc
072 7 $a MED027000 $2 bisacsh
072 7 $a HEA039050 $2 bisacsh
082 0 4 $a 617.735 $2 23
090 $a RE661.D5 $b S851 2017
100 1 $a Stewart, Michael W. $3 1141855
245 1 0 $a Diabetic retinopathy $h [electronic resource] : $b current pharmacologic treatment and emerging strategies / $c by Michael W. Stewart.
260 $a Singapore : $b Springer Singapore : $b Imprint: Adis, $c 2017.
300 $a xiii, 268 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Diabetes and Diabetic Retinopathy: Overview Of A World-Wide Epidemic -- 2. The Diabetic Retina: Anatomy and Pathophysiology -- 3. Treatment of Diabetic Retinopathy: A Historical Perspective -- 4. Targeting Vascular Endothelial Growth Factor -- 5. Corticosteroids: Targeting Multiple Cytokines and Chemokines -- 6. Current Treatment Recommendations -- 7. Vitreolysis: Targeting the Vitreoretinal Interface -- 8. Investigational Medications -- 9. Safety Considerations of Pharmacotherapy -- 10. Socioeconomic Cost of Diabetic Retinopathy and Therapy.
520 $a A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets. Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option. Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed.
650 0 $a Diabetic retinopathy. $3 781324
650 0 $a Diabetic retinopathy $x Treatment. $3 882232
650 0 $a Pharmacology. $3 583819
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Diabetes. $3 582755
650 2 4 $a Ophthalmology. $3 644487
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-3509-8
950 $a Medicine (Springer-11650)